Sharescart Research Club logo

Vax Hsg. Fin. Corp. Overview

1. Business Overview

Vax Housing Finance Corporation Ltd. is an Indian non-deposit-taking housing finance company (HFC). Its core business involves providing financial assistance primarily for housing-related purposes. This typically includes home loans for the purchase or construction of residential properties, as well as loans for renovation, extension, and sometimes plots. The company generates revenue primarily through the interest income earned on these loans and, to a lesser extent, through processing fees and other service charges.

2. Key Segments / Revenue Mix

Given its name and industry, Vax Housing Finance Corporation Ltd. primarily operates in a single key segment: housing finance. Its loan book is predominantly composed of various types of housing loans. Specific breakdowns of revenue contribution by sub-segment (e.g., home purchase, construction, plot loans, loan against property) are not publicly available, but the overwhelming majority of its revenue would be derived from interest on its housing loan portfolio.

3. Industry & Positioning

The Indian housing finance industry is dynamic and highly competitive, comprising large public and private sector banks, national HFCs, and smaller regional HFCs like Vax. The industry is characterized by strong demand driven by urbanization, a young population, rising incomes, and government incentives (e.g., PMAY). Vax Housing Finance likely positions itself as a niche or regional player, potentially focusing on specific customer segments such as self-employed individuals, customers in tier 2/3 cities, or those seeking affordable housing solutions, where larger banks might have less presence or more rigid eligibility criteria.

4. Competitive Advantage (Moat)

For smaller HFCs like Vax, durable competitive advantages (moats) are generally limited compared to larger, established players. Potential advantages might include:

Local Market Knowledge & Relationships: Strong understanding of local real estate markets and borrower profiles in specific geographies.

Niche Focus & Underwriting: Ability to efficiently underwrite and serve specific segments (e.g., unbanked, informal sector) that larger institutions may overlook or find too risky.

Agility & Service: Potentially faster decision-making and more personalized service due to a smaller operational scale.

However, Vax is unlikely to possess significant moats related to brand recognition, scale, or extensive distribution networks that characterize larger competitors.

5. Growth Drivers

Growing Housing Demand: India's significant housing deficit, rising urbanization, and increasing disposable incomes continue to fuel demand for home ownership.

Government Initiatives: Programs like Pradhan Mantri Awas Yojana (PMAY) provide subsidies and incentives, boosting affordable housing demand.

Increased Credit Penetration: Growth opportunities exist in extending credit to underserved segments and new geographies, especially in semi-urban and rural areas.

Lower Interest Rates (Historically): A conducive interest rate environment can make home loans more affordable and stimulate demand.

Formalization of Economy: Increased formalization benefits HFCs by making credit assessment easier for previously informal borrowers.

6. Risks

Credit Risk: Potential for non-performing assets (NPAs) arising from borrower defaults, especially from segments with less formal income documentation or economic downturns affecting repayment capacity.

Interest Rate Risk: Asset-liability mismatch (ALM) if funding costs rise faster than the ability to reprice loans, impacting net interest margins.

Funding Risk: Reliance on bank borrowings or market-based funding makes it susceptible to liquidity tightening or adverse changes in capital market conditions.

Competition: Intense competition from larger banks and HFCs can lead to margin pressure and difficulty in acquiring quality customers.

Regulatory Changes: Adverse changes in regulations by the National Housing Bank (NHB) or Reserve Bank of India (RBI) regarding capital adequacy, asset classification, or lending norms could impact operations.

Economic Slowdown: A general economic downturn could negatively impact employment, incomes, and real estate prices, leading to higher delinquencies.

7. Management & Ownership

Typically for smaller, non-deposit-taking HFCs in India, ownership is often closely held, frequently by promoter families or a small group of investors. The management team generally comprises professionals with experience in housing finance, risk management, and local market operations. The promoter group is likely to have a significant equity stake, indicating alignment with long-term company performance. Detailed information on management quality and specific ownership structure beyond public filings would require deeper due diligence.

8. Outlook

Vax Housing Finance operates in a structurally growing market with significant long-term potential for housing finance in India. The sustained demand for affordable housing, coupled with government support, provides a favorable environment for growth. However, as a smaller player, it faces intense competition from well-capitalized banks and larger HFCs, which possess greater financial muscle, distribution reach, and brand equity. Its ability to navigate a competitive landscape while maintaining prudent asset quality, ensuring diversified and cost-effective funding, and adhering to evolving regulatory frameworks will be critical for sustained profitability and growth. Success will hinge on its execution within its chosen niche, efficient risk management, and capacity to scale operations judiciously.

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

Vax Hsg. Fin. Corp. Key Financials

Market Cap ₹3 Cr.

Stock P/E -1463.2

P/B -

Current Price ₹2.6

Book Value ₹ 0

Face Value 10

52W High ₹0

Dividend Yield 0%

52W Low ₹ 0

Vax Hsg. Fin. Corp. Share Price

| |

Volume
Price

Vax Hsg. Fin. Corp. Quarterly Price

Show Value Show %

Vax Hsg. Fin. Corp. Peer Comparison

Vax Hsg. Fin. Corp. Quarterly Results

#(Fig in Cr.) Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
Net Sales 0 0 0 0 0 0 0 0 0 0
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 0 0 0 0 0 0 0 0 0 0
Total Expenditure 0 0 0 0 0 0 0 0 0 0
Operating Profit 0 -0 0 -0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 -0 0 -0 0 0 0 -0 0 0
Provision for Tax 0 0 0 0 0 0 0 0 0 0
Profit After Tax 0 -0 0 -0 0 0 0 -0 0 0
Adjustments 0 0 0 0 0 0 0 -0 0 0
Profit After Adjustments 0 -0 0 -0 0 0 0 -0 0 0
Adjusted Earnings Per Share 0 -0 0 -0 0 0 0 -0 0 0

Vax Hsg. Fin. Corp. Profit & Loss

#(Fig in Cr.) Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
Net Sales 8 15 7 9 0 0 0 0 0 0 0 0
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Total Income 8 15 7 9 1 0 0 0 0 0 0 0
Total Expenditure 8 15 7 9 0 0 0 0 0 0 0 0
Operating Profit 1 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1 0 0 0 0 -0 0 0 0 -0 -0 0
Provision for Tax 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Tax 0 0 0 0 0 -0 0 0 0 -0 -0 0
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 0 0 0 0 0 -0 0 0 0 -0 -0 0
Adjusted Earnings Per Share 0.4 0 0 0.1 0 -0 0 0 0 -0 -0 0

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 0% 0% 0% -100%
Operating Profit CAGR 0% 0% 0% -100%
PAT CAGR 0% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 0% 16% 20% -12%
ROE Average -0% -0% 0% 0%
ROCE Average -0% 0% 0% 0%

Vax Hsg. Fin. Corp. Balance Sheet

#(Fig in Cr.) Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Shareholder's Funds 43 43 43 43 43 43 43 43 43 43 43
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0 0
Total Current Liabilities 5 2 1 1 1 1 1 1 1 1 1
Total Liabilities 48 44 43 44 44 43 43 43 43 43 44
Fixed Assets 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 33 31 28 40 42 42 42 42 42 43 43
Total Current Assets 14 13 15 4 2 2 2 2 2 1 1
Total Assets 48 44 43 44 44 43 43 43 43 43 44

Vax Hsg. Fin. Corp. Cash Flow

#(Fig in Cr.) Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Opening Cash & Cash Equivalents 0 0 0 0 0 0 0 0 0 0 0
Cash Flow from Operating Activities -22 0 0 0 0 -0 -0 -0 -0 -0 0
Cash Flow from Investing Activities -15 0 0 0 0 0 0 0 0 0 0
Cash Flow from Financing Activities 37 0 0 0 0 0 0 0 0 0 0
Net Cash Inflow / Outflow -0 0 0 0 0 -0 -0 -0 -0 -0 0
Closing Cash & Cash Equivalent 0 0 0 0 0 0 0 0 0 0 0

Vax Hsg. Fin. Corp. Ratios

# Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Earnings Per Share (Rs) 0.41 0.04 0.04 0.05 0.04 -0 0 0 0 -0 -0
CEPS(Rs) 0.45 0.06 0.06 0.1 0.04 0 0.01 0.01 0.01 0 0
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 35.32 35.48 35.51 35.56 35.6 35.6 35.6 35.6 35.61 35.6 35.6
Core EBITDA Margin(%) 5.14 0.61 1.26 1.31 2.56 0 0 0 0 0 0
EBIT Margin(%) 8.81 0.4 0.93 0.96 9.68 0 0 0 0 0 0
Pre Tax Margin(%) 8.78 0.4 0.93 0.96 9.63 0 0 0 0 0 0
PAT Margin (%) 6.15 0.29 0.61 0.66 8.81 0 0 0 0 0 0
Cash Profit Margin (%) 6.7 0.5 0.95 1.31 10.94 0 0 0 0 0 0
ROA(%) 1.81 0.09 0.1 0.14 0.1 -0.01 0 0.01 0 -0 -0
ROE(%) 2.07 0.1 0.11 0.14 0.1 -0.01 0 0.01 0.01 -0 -0
ROCE(%) 2.96 0.14 0.16 0.21 0.11 -0 0.01 0.01 0.02 -0 -0
Receivable days 352.36 339.77 696.17 366.03 1507.56 0 0 0 0 0 0
Inventory Days 0 0 0 0 0 0 0 0 0 0 0
Payable days 0 20.69 21.8 5.75 260.96 0 0 0 0 0 0
PER(x) 31.85 276.7 218.79 125.8 264.07 0 3785.92 833.33 738.89 0 0
Price/Book(x) 0.37 0.27 0.23 0.18 0.27 0.17 0.11 0.07 0.04 0.04 0.04
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 1.96 0.79 1.32 0.82 23.07 0 0 0 0 0 0
EV/Core EBITDA(x) 20.92 128.62 104.03 50.51 195.19 792.72 460.93 223.34 114.46 345 742.35
Net Sales Growth(%) 7.13 84.42 -49.73 23.65 -94.66 -100 0 0 0 0 0
EBIT Growth(%) -27.74 -91.63 17.49 27.63 -46.32 -103.29 258.61 102.75 48.65 -104.03 -333.33
PAT Growth(%) -26.79 -91.41 6.61 33.43 -28.28 -113.02 122.22 192.17 -41.52 -165.76 -50
EPS Growth(%) -69.48 -91.4 6.47 33.41 -28.2 -113.09 122.09 189 -40 -166.67 -41.67
Debt/Equity(x) 0 0 0 0 0 0 0 0 0 0 0
Current Ratio(x) 2.68 8.23 20.91 4.21 2.32 2.6 2.63 2.61 2.46 1.16 1.11
Quick Ratio(x) 2.68 8.23 20.91 4.21 2.32 2.6 2.63 2.61 2.46 1.16 1.11
Interest Cover(x) 402.43 490.16 577.81 238.31 195.63 0 104.64 120.94 300.11 -1 -4.33
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0

Vax Hsg. Fin. Corp. Shareholding Pattern

# Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
Promoter 1.38 1.38 1.38 1.38 1.38 1.38 1.38 1.38 1.38 1.38
FII 0 0 0 0 0 0 0 0 0 0
DII 0 0 0 0 0 0 0 0 0 0
Public 98.62 98.62 98.62 98.62 98.62 98.62 98.62 98.62 98.62 98.62
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Vax Hsg. Fin. Corp. News

Vax Hsg. Fin. Corp. Pros & Cons

Pros

  • Company is almost debt free.

Cons

  • Promoter holding is low: 1.38%.
  • Company has a low return on equity of -0% over the last 3 years.
whatsapp